{"": [113, 1311, 0], "Key Summary Points": [1312, 1338, 0], "Introduction": [1339, 4193, 0], "Methods": [4194, 5353, 0], "COVID-19 Characteristics": [5417, 6311, 0, 9593, 10656, 0, 13187, 14281, 0, 16063, 17719, 0, 20349, 22105, 0], "Vaccination Response": [6312, 9561, 0, 10657, 13172, 0, 14282, 16027, 0, 17720, 20343, 0, 22106, 23680, 0], "Malignancy": [5405, 9561, 1], "Chronic Inflammatory Diseases": [9562, 13172, 1], "Hemodialysis": [13173, 16027, 1], "Solid Organ Transplant Recipients": [16028, 20343, 1], "HIV": [20344, 23680, 1], "Outcomes in Specific Immunocompromised Conditions": [5354, 23680, 1], "Additional COVID-19 Vaccine Doses for Immunocompromised Individuals": [23681, 28243, 0], "Discussion": [28244, 32571, 0], "Conclusion": [32572, 33058, 0]}